Rhythm Pharmaceuticals Inc (RYTM) — Cash Flow Quality Index

Latest as of March 2021: -0.77x

Rhythm Pharmaceuticals Inc (RYTM) has a Cash Flow Quality Index of -0.77x as of March 2021. Operating cash flow of $-33.53 Million is below net income of $43.75 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Rhythm Pharmaceuticals Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

-0.77x
Operating CF / Net Income

Operating Cash Flow

$-33.53 Million
USD

Net Income

$43.75 Million
USD

Data as of

Mar 2021
Most recent filing

Annual Cash Flow Quality Index for Rhythm Pharmaceuticals Inc (None–None)

Year-by-year earnings quality comparison for Rhythm Pharmaceuticals Inc. For live market cap and the full company financial profile, see Rhythm Pharmaceuticals Inc market capitalisation.

Year Quality Index Operating CF (USD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.